Joshua R. Disbrow
2019 - AYTU BIOPHARMA
In 2019, Joshua R. Disbrow earned a total compensation of $1M as Chief Executive Officer since December at AYTU BIOPHARMA, a 72% increase compared to previous year.
Compensation breakdown
| Bonus | $135,000 |
|---|---|
| Salary | $330,000 |
| Stock Awards | $578,705 |
| Total | $1,043,705 |
Disbrow received $578.7K in stock awards, accounting for 55% of the total pay in 2019.
Disbrow also received $135K in bonus and $330K in salary.
Rankings
In 2019, Joshua R. Disbrow's compensation ranked 9,101st out of 13,971 executives tracked by ExecPay. In other words, Disbrow earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,101 out of 13,971 | 35th |
Division Manufacturing | 3,652 out of 5,701 | 36th |
Major group Chemicals And Allied Products | 1,381 out of 2,200 | 37th |
Industry group Drugs | 1,178 out of 1,886 | 38th |
Industry Pharmaceutical Preparations | 872 out of 1,398 | 38th |
Source: SEC filing on March 5, 2020.
Disbrow's colleagues
We found three more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2019.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019